engleski

How to measure cognitive abilities in cancer patients (Computerized Psychometric Testing by Complex Reactiometer Drenovac)

Cancer patients are very vulnerable to neurocognitive dysfunction. One of the most complex problems in previous studies was how to measure cognition. Some of the tests used in clinical practice are not sufficiently sensitive. Other tests are too expensive and sophisticated to be used in everyday work. We used computerized laboratory—Complex Reactiometer Drenovac (CRD) for that purpose.

Cognition ; Cancer ; CRD

nije evidentirano